A Young Man's Testimonial for Avastin

Later this week, on December 17, the FDA will reconsider its approval of the cancer drug Avastin (bevacizumab )because of concerns that it has not been effective against most breast cancers. It has, however, had success as treatment for triple-negative. Josh Turnage, a sophomore at Mississippi State University, says the drug saved his mother, and he has lobbied for its continuance. His essay about his mother's experience has appeared in media all around the country. The SF Gate version is here. He also created a video to help make his case.